Literature DB >> 16808742

Lack of adherence with preoperative B-blocker recommendations in a multicenter study.

Debra Quinn Kolodner1, Huong Do, Mary Cooper, Eliot Lazar, Mark Callahan.   

Abstract

BACKGROUND: Clinical guidelines support the use of preoperative B-blocker in select patients. Patient safety groups have sought to measure the level of adherence to these recommendations.
OBJECTIVE: This study was performed to compare the utilization of preoperative B-blocker with current guidelines across multiple diverse institutions.
DESIGN: Retrospective chart review was performed of inpatients undergoing noncardiac surgery across 5 hospital centers during 2003 to 2004. The primary outcome of interest was the administration of preoperative B-blocker. PARTICIPANTS: The study sample included 1,304 randomly selected patients meeting the guideline criteria for preoperative B-blockade.
MEASUREMENTS AND MAIN RESULTS: Among patients meeting recommendations for preoperative B-blocker, only 44% (430/983) received B-blocker before surgery. Patients who had not previously received B-blocker were given B-blocker before surgery in only 14% (85/600) of cases. Target heart rates goals for perioperative B-blockade were achieved in 26% (113/430) of cases. Predictors for initiating preoperative B-blocker included nonelective surgery or a history of hypertension or diabetes. Individual hospitals were independently predictive of preoperative B-blocker administration in multivariable models.
CONCLUSIONS: Preoperative B-blocker was significantly underutilized when compared with the current guideline recommendations. Target heart rate goals were not achieved in clinical practice, and few hospitalized patients had preoperative B-blockade initiated. The lack of adherence to preoperative B-blocker recommendations in practice may be impacted by ongoing clinical questions regarding the appropriate selection of candidates for this therapy. Further efforts toward achieving guideline recommendations for preoperative B-blocker use should be focused on the subset of patients that are uniformly agreed upon to be at high risk for cardiac events.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16808742      PMCID: PMC1924621          DOI: 10.1111/j.1525-1497.2006.00408.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  22 in total

1.  Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery.

Authors:  M Zaugg; T Tagliente; E Lucchinetti; E Jacobs; M Krol; C Bodian; D L Reich; J H Silverstein
Journal:  Anesthesiology       Date:  1999-12       Impact factor: 7.892

2.  Effectiveness of preprinted order forms in promoting perioperative beta-blocker use.

Authors:  John B Pollard; Rebecca C Chow; Jeffrey R Hansen
Journal:  Am J Health Syst Pharm       Date:  2002-02-15       Impact factor: 2.637

3.  beta-Blockers and reduction of cardiac events in noncardiac surgery: clinical applications.

Authors:  Andrew D Auerbach; Lee Goldman
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

Review 4.  Peri-operative beta-blockade: a useful treatment that should be greeted with cautious enthusiasm.

Authors:  S J Howell; J W Sear; P Foex
Journal:  Br J Anaesth       Date:  2001-02       Impact factor: 9.166

5.  The future of anesthesiology is perioperative medicine.

Authors:  P Rock
Journal:  Anesthesiol Clin North Am       Date:  2000-09

6.  Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy.

Authors:  E Boersma; D Poldermans; J J Bax; E W Steyerberg; I R Thomson; J D Banga; L L van De Ven; H van Urk; J R Roelandt
Journal:  JAMA       Date:  2001-04-11       Impact factor: 56.272

7.  Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study.

Authors:  Donald Redelmeier; Damon Scales; Alexander Kopp
Journal:  BMJ       Date:  2005-10-06

8.  The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.

Authors:  D Poldermans; E Boersma; J J Bax; I R Thomson; L L van de Ven; J D Blankensteijn; H F Baars; T I Yo; G Trocino; C Vigna; J R Roelandt; H van Urk
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

9.  Outpatient adherence to beta-blocker therapy after acute myocardial infarction.

Authors:  Javed Butler; Patrick G Arbogast; Rhonda BeLue; James Daugherty; Manoj K Jain; Wayne A Ray; Marie R Griffin
Journal:  J Am Coll Cardiol       Date:  2002-11-06       Impact factor: 24.094

10.  Knowledge and practice regarding prophylactic perioperative beta blockade in patients undergoing noncardiac surgery: a survey of Canadian anesthesiologists.

Authors:  Elizabeth G VanDenKerkhof; Brian Milne; Joel L Parlow
Journal:  Anesth Analg       Date:  2003-06       Impact factor: 5.108

View more
  4 in total

1.  Comment on "Lack of adherence with perioperative B-blocker recommendations in a multicenter study".

Authors:  Katayoun Mostafaie; Darrell W Harrington
Journal:  J Gen Intern Med       Date:  2006-12       Impact factor: 5.128

2.  Anesthesiologists' preferences for preoperative cardiac evaluation before vascular surgery: results of a mail survey.

Authors:  John E Ellis; Avery Tung; Helen Lee; Hubert Lee; Kristen Kasza
Journal:  J Clin Anesth       Date:  2010-09       Impact factor: 9.452

3.  β-blocker withdrawal among patients presenting for surgery from home.

Authors:  Robert B Schonberger; Carrie L Lukens; O Dicle Turkoglu; Jessica L Feinleib; Kenneth L Haspel; Matthew M Burg
Journal:  J Cardiothorac Vasc Anesth       Date:  2012-03-13       Impact factor: 2.628

4.  Elevated preoperative blood pressures in adult surgical patients are highly predictive of elevated home blood pressures.

Authors:  Robert B Schonberger; Adambeke Nwozuzu; Jill Zafar; Eric Chen; Simon Kigwana; Miriam M Monteiro; Jean Charchaflieh; Sophisa Sophanphattana; Feng Dai; Matthew M Burg
Journal:  J Am Soc Hypertens       Date:  2018-02-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.